publication . Article . 2011

Pharmacokinetics and pharmacodynamics of antibacterial agents: on account of febrile neutropenic patients

Javier R Garzón; Sonia I Cuervo M; Julio Gómez R; Jorge Cortés;
Open Access Spanish
  • Published: 01 Dec 2011
  • Publisher: Sociedad Chilena de Infectología
Resumen La neutropenia febril es una complicacion grave de la terapia antineoplasica que se presenta mas frecuentemente en pacientes con neoplasias hematologicas, asociada a tasas elevadas de mortalidad. Uno de los factores des-critos como causa de fracasos terapeuticos de la terapia antimicrobiana es la inadecuada concentracion tisular de los antimicrobianos que a su vez se correlaciona con bajas concentraciones en el liquido intersticial en el caso de los farmacos hidrofilicos. En pacientes criticamente enfermos se puede presentar acumulacion compartimental de liquidos que a su vez se puede asociar con aumento en el volumen de distribucion de los medicamentos ...
Persistent Identifiers
free text keywords: Anti-infective agents, administration & dosage, therapeutic use, drug therapy, standards, fever, drug therapy, etiology, humans, hematologic neoplasms, complications, neutropenia, etiology, Agentes antibacterianos, administración & dosificación, uso terapéutico, terapéutica, fiebre, etiología, terapia, humanos, neoplasias hematológicas, complicaciones, neutropenia, terapia, administración & dosificación, Infectious Diseases, Public Health, Environmental and Occupational Health, Chilena, biology.organism_classification, biology, Cancer, medicine.disease, medicine, Current spectrum, Gynecology, medicine.medical_specialty, Cooperative group, business.industry, business, Neutropenia, INT, Antibiotic therapy, Febrile neutropenia, Surgery
Related Organizations
65 references, page 1 of 5

1.- Hughes W, Armstrong D,Bodey G, Bow E, Brown A, Calandra T, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-51.

2.- Sculier J P, Weerts D, Klastersky J. Causes of death in granulocytopenic cancer patients receiving empiric antibiotic therapy. Eur J Cancer Clin Oncol; 20 (1): 55-60.

3.- Rossi C, Klastersky J. Initial antibiotic empirical therapy for neutropenic fever: analysis of the causes of death. Support Care Cancer 1996; 4 (3): 207-12.

4.- Muñoz O, Rodelo A, Carvajal J, González J, Jaimes F. Características clínicas y microbiológicas de los pacientes neutropénicos febriles con neoplasias hematológicas. Iatreia 2008; 21 (1): s9.

5.- Viscoli C, Varnier O, Machetti M L. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis 2005; 40: S240-5.

6.- Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 1997; 99 (3): 580-8.

7.- Meckler G, Lindemulder S. Fever and neutropenia in pediatric patients with cancer. Emerg Med Clin North Am 2009; 27 (3): 525-44. [OpenAIRE]

8.- Hakim H, Flynn P M, Knapp K M, Srivastava D K, Gaur A H. Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 2009; 31 (9): 623-9.

9.- Badiei Z, Khalesi M, Alami M H, Kianifar H R, Banihashem A, Farhangi H, et al. Risk factors associated with life-threatening infections in children with febrile neutropenia: a data mining approach. J Pediatr Hematol Oncol 2011; 33 (1): e9-e12.

10.- Scaglione F, Paraboni L. Pharmacokinetics/ pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens. Int J Antimicrob Agents 2008; 32: 294-301. [OpenAIRE]

11.- Lortholary O, Lefort A, Tod M, Chomat A, Darras-Joly C, Cordonnier C. Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia. Lancet Infect Dis 2008; 8: 612-20. [OpenAIRE]

12.- Rolston K. Challenges in the treatment of infections caused by gram-positive and gramnegative bacteria in patients with cancer and neutropenia. Clin Infect Dis 2005; 40: S246-52. [OpenAIRE]

13.- Padrón N, Menéndez S. Infecciones en el paciente neutropénico con cáncer. Rev Panam Infectol 2006; 8 (3): 24-34.

14.- Sipsas N, Bodey G, Kontoyiannis D. Perspectives for the management of febrile neutropenic patients with cancer in the 21st Century. Cancer 2005; 103 (6): 1103-13.

15.- Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999; 29 (3): 490-4.

65 references, page 1 of 5
Any information missing or wrong?Report an Issue